Renal Cancer - Results from #8880

Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery - Abstract July 6, 2011

Second-line treatment of advanced renal cell carcinoma after first-line targeted therapy - Abstract July 6, 2011

Recent developments in kidney cancer - Abstract July 5, 2011

Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma - Abstract July 5, 2011

Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma - Abstract July 4, 2011

Improved targeting of radio-frequency ablation probes and thermal sensors: A preliminary investigation of flat-panel CT-guided ablation of renal tumors performed in the cardiac catheterization laboratory - Abstract July 4, 2011

Stage pT3a of renal clear cell carcinoma: Do tumors with sinus fat involvement behave the same as those with perinephric fat involvement? - Abstract July 1, 2011

Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): A randomised phase 2 trial - Abstract July 1, 2011

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma? - Abstract June 30, 2011

Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma - Abstract June 30, 2011

Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group - Abstract June 29, 2011

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma - Abstract June 29, 2011

Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival - Abstract June 28, 2011

Pfizer files with the FDA for review of axitinib for patients with advanced renal cell carcinoma June 28, 2011

Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma - Abstract June 27, 2011

Management of metastatic renal cell carcinoma in the era of targeted therapies - Abstract June 24, 2011

Feasibility and adequacy of robot-assisted lymphadenectomy for renal-cell carcinoma - Abstract June 24, 2011

Renal cell carcinoma of the native kidney: A frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis - Abstract June 23, 2011

Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma - Abstract June 23, 2011

Efficacy of sunitinib re-exposure after failure of an mTOR inhibitor in patients with metastatic RCC - Abstract June 23, 2011

Page 445 of 455